Literature DB >> 11004105

At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98.

A C Moll1, S M Imhof, A Y Meeteren, M Boers.   

Abstract

AIM: To evaluate until what age children in families with retinoblastoma should be screened.
METHODS: A register based cohort (n= 685) study of Dutch retinoblastoma patients (1945-1998). The records of all familial hereditary retinoblastoma patients from 1945 were reviewed and the age at diagnosis and either they were screened from birth determined.
RESULTS: 75 patients had the familial hereditary form of retinoblastoma. The mean age at diagnosis in patients with fundus screening (n=50) from birth on was 4.9 months (median 1.9 months; range 1 day to 48 months). Thus, 4 years was the latest onset of familial retinoblastoma properly evaluated from birth. This mean age was significantly different (p<0.0001) from the mean age at diagnosis in patients without fundus screening (n=25) from birth (mean 17.2 months; median 10.0 months; range 1.5-63.0 months).
CONCLUSIONS: Ophthalmological screening of children and sibs at risk for familial hereditary retinoblastoma is recommended until the age of 4 years in order to detect retinoblastoma as early as possible.

Entities:  

Mesh:

Year:  2000        PMID: 11004105      PMCID: PMC1723250          DOI: 10.1136/bjo.84.10.1170

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Retinoblastoma. Review of the current status.

Authors:  J O Bishop; E C Madson
Journal:  Surv Ophthalmol       Date:  1975 May-Jun       Impact factor: 6.048

2.  Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994.

Authors:  A C Moll; S M Imhof; L M Bouter; D J Kuik; W Den Otter; P D Bezemer; J W Koten; K E Tan
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

3.  Parents with unilateral retinoblastoma: their affected children.

Authors:  C M Notis; K Niksarli; D H Abramson; A R DeLillo; R M Ellsworth
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

4.  Retinoblastoma in older children.

Authors:  C L Shields; J A Shields; P Shah
Journal:  Ophthalmology       Date:  1991-03       Impact factor: 12.079

5.  Unilateral vs. bilateral retinoblastoma. Correlations between age at diagnosis and stage of ocular disease.

Authors:  M Rubenfeld; D H Abramson; R M Ellsworth; F D Kitchin
Journal:  Ophthalmology       Date:  1986-08       Impact factor: 12.079

6.  Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening.

Authors:  J W Harbour
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

Review 7.  Genetics of retinoblastoma.

Authors:  F Vogel
Journal:  Hum Genet       Date:  1979-11-01       Impact factor: 4.132

8.  Hydroxyapatite orbital implant after enucleation. Experience with initial 100 consecutive cases.

Authors:  C L Shields; J A Shields; P De Potter
Journal:  Arch Ophthalmol       Date:  1992-03

9.  A simplified scheme for genetic counseling in retinoblastoma.

Authors:  M A Musarella; B L Gallie
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1987 May-Jun       Impact factor: 1.402

10.  Patterns of risk of hereditary retinoblastoma and applications to genetic counselling.

Authors:  G J Draper; B M Sanders; P A Brownbill; M M Hawkins
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more
  5 in total

1.  Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study.

Authors:  P-R Rothschild; D Lévy; A Savignoni; L Lumbroso-Le Rouic; I Aerts; M Gauthier-Villars; M Esteve; D Bours; L Desjardins; F Doz; C Lévy-Gabriel
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

2.  Preserving vision in retinoblastoma through early detection and intervention.

Authors:  Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

3.  Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in the Netherlands.

Authors:  S M Imhof; A C Moll; A Y N Schouten-van Meeteren
Journal:  Br J Ophthalmol       Date:  2006-04-13       Impact factor: 4.638

Review 4.  Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Authors:  Junne Kamihara; Franck Bourdeaut; William D Foulkes; Jan J Molenaar; Yaël P Mossé; Akira Nakagawara; Andreu Parareda; Sarah R Scollon; Kami Wolfe Schneider; Alison H Skalet; Lisa J States; Michael F Walsh; Lisa R Diller; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

5.  Retinoblastoma in older patients: A retrospective comparative analysis of 100 consecutive patients based on age.

Authors:  Babak Masoomian; Lauren A Dalvin; Michael D Yu; Christina Stathopoulos; Carol L Shields
Journal:  Saudi J Ophthalmol       Date:  2019-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.